Related Experiment Videos
Sarcomatoid chordoma: chordoma with a massive malignant spindle-cell component
Y Morimitsu1, T Aoki, K Yokoyama
1Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Japan.
Skeletal Radiology
|March 29, 2001
Summary
This study describes a rare sarcomatoid chordoma, a bone tumor with both conventional and spindle cell components. Recognizing this rare tumor aids in differential diagnosis, preventing misclassification with other spindle cell neoplasms.
Area of Science:
- Oncology
- Pathology
- Skeletal Tumors
Background:
- Chordomas are rare malignant bone tumors arising from notochordal remnants.
- Spindle cell sarcomatoid differentiation is an uncommon feature in chordomas.
Observation:
- A case of chordoma exhibiting a gradual transition from conventional chordoma to a spindle cell sarcomatoid component is presented.
- Immunohistochemical analysis revealed tumor cells positive for cytokeratins (AE1/AE3, CAM5.2), epithelial membrane antigen, and vimentin in both components.
Findings:
- The study identifies a rare variant: sarcomatoid chordoma.
- Immunohistochemical markers support epithelial and mesenchymal differentiation in both tumor components.
Implications:
- This case highlights the importance of recognizing sarcomatoid chordoma.
- Awareness of this entity is crucial for accurate diagnosis, distinguishing it from dedifferentiated chordoma and other spindle cell tumors like sarcomas and carcinomas.